Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00762021 · ClinicalTrials.gov registry record · NA
Posterior Capsule Opacification (PCO) Evaluation of the AcrySof SN60AT Lens vs. SN60WF Lens
A NA study of Cataract, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT00762021: Completed NA study of Cataract, sponsored by Alcon Research.
NCT00762021 is a NA study of Cataract that has completed, run by Alcon Research. The registered enrollment target is 104 participants, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00762021, a NA study of Cataract, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess posterior capsule opacification (PCO) in patients implanted with either the AcrySof SN60AT lens or the AcrySof SN60WF lens.
Primary Outcome
Thickening and opacification of the transparent membrane on which the intraocular lens is placed assessed by taking a digital retroillumination image of each eye with a dedicated retroillumination camera system. The photographs were analyzed with POCO software to measure the percentage area of PCO in the capsulorhexis area.
Conditions Studied
Interventions
- DEVICE SN60AT
- DEVICE SN60WF
Study Locations (1)
Texas
- Contact Alcon Call Center for Trial Locations - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2006-12 |
| Phase | NA |
What the finished NCT00762021 record still lists
NCT00762021 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 227-participant average among 83 other Cataract trials with a reported enrollment target (54% lower).
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 2 interventions - of which SN60AT is the first listed.
NCT00762021 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00762021 about?
NCT00762021 is a clinical study titled "Posterior Capsule Opacification (PCO) Evaluation of the AcrySof SN60AT Lens vs. SN60WF Lens". To assess posterior capsule opacification (PCO) in patients implanted with either the AcrySof SN60AT lens or the AcrySof SN60WF lens.
What is the current status of trial NCT00762021?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2006-12.
What conditions does trial NCT00762021 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT00762021?
The interventions under investigation include: SN60AT (DEVICE), SN60WF (DEVICE).
Who is sponsoring clinical trial NCT00762021?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00762021 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00762021's enrollment target sits among peer trials
104 36th of 83 higher than 48 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Unity VCS: A Comparison Study Evaluating Corneal Clarity and Thickness
RECRUITING · NA
-
Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery
RECRUITING · NA
-
Quatera 700 vs. Centurion
ACTIVE NOT RECRUITING · NA
-
Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study
ACTIVE NOT RECRUITING · NA
-
Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia